Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?
Zwaginga
J J
JJ
Department of Experimental Immunohaematology, Sanquin Research, Amsterdam, The Netherlands. j.j.zwaginga@lumc.nl
Sakariassen
K S
KS
King
M R
MR
Diacovo
T G
TG
Grabowski
E F
EF
Nash
G
G
Hoylaerts
M
M
Heemskerk
J W M
JW
D001777:Blood Coagulation; D001780:Blood Coagulation Tests / Q000295:instrumentation* / Q000592:standards; D002138:Calibration; D004867:Equipment Design; D006801:Humans; D010641:Phenotype; D017410:Practice Guidelines as Topic; D012039:Regional Blood Flow; D015203:Reproducibility of Results; D013314:Stress, Mechanical; D014842:von Willebrand Diseases / Q000097:blood / Q000145:classification / Q000175:diagnosis* / Q000503:physiopathology; D014841:von Willebrand Factor / Q000378:metabolism*
D014841:von Willebrand Factor